Original Paper
Online First™Systems GMM estimates of the health care spending and GDP relationship: a note
Saten Kumar
Online First™, 13 May 2012
Original Paper
Online First™Drug expenditure of high-cost patients and their characteristics in Finland
Leena K. Saastamoinen and Jouko Verho
Online First™, 12 May 2012
Original Paper
Online First™Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales
Ruth E. Brown, Sean Stern, Sujith Dhanasiri and Steve Schey
Online First™, 10 May 2012
Commentary
Online First™The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator
Mattias Neyt and Ann Van Den Bruel
Online First™, 10 May 2012
Original Paper
Online First™Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland
Jonas Nilsson, Örjan Åkerborg, Gaëlle Bégo-Le Bagousse, Mårten Rosenquist and Peter Lindgren
Online First™, 3 May 2012
Original Paper
Online First™The impact of time cost of physical exercise on health outcomes by older adults: the DR’s EXTRA Study
Virpi Kuvaja-Köllner, Hannu Valtonen, Pirjo Komulainen, Maija Hassinen and Rainer Rauramaa
Online First™, 25 April 2012
Original Paper
Online First™Does the US health care safety net discourage private insurance coverage?
Xuezheng Qin and Gordon G. Liu
Online First™, 23 April 2012
Original Paper
Online First™Diffusion of innovations in social interaction systems. An agent-based model for the introduction of new drugs in markets
Julio Pombo-Romero, Luis M. Varela and Carlos J. Ricoy
Online First™, 9 April 2012
Original Paper
Online First™Welfare-related health inequality: does the choice of measure matter?
Joachim R. Frick and Nicolas R. Ziebarth
Online First™, 24 March 2012
Original Paper
Online First™Bargaining and the provision of health services
Luigi Siciliani and Anderson Stanciole
Online First™, 15 March 2012